In the second half of 2021 the number of equity offerings decreased significantly by 75% from the same period in 2020.
This marks a deceleration in growth from the 36.4% decrease in deals that occurred in H1 2021 relative to the same period a year earlier.
During this time, the region that saw the biggest increase in the number of deals was North America.
Deals rose by 66.7% in the region.
From the second half of 2020 to the second half of 2021, the largest regional increase in deals was also seen in North America.
During second half of 2021, equity offerings accounted for 0.4% of all deals taking place in the sector. This represents no change from the figure of 0.4% in second half of 2020.
GlobalData's deals database is a comprehensive repository that looks at mergers, acquisitions, venture financing, equity offerings, asset transactions, partnerships and debt offerings taking place daily between thousands of companies across the world.
The database details key deal information, such as deal summary, deal rationale, deal financials, parties involved, advisors and deal payment modes.
By tracking the proportion of various types of deals in each sector we can gauge which sectors are seeing growth and where others are struggling.
The highest value equity offering announced in 2021 (where the deal value was known), is the financing to be raised by Venus Medtech through a private placement of H shares.
The deal is set to be worth $188.1 million.
The database states that the rationale behind this deal was as follows: "Venus Medtech intends to use the proceeds to facilitate the sustainable development and satisfy its requirements for capital in light of the rapid development of the business."